Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431).
about
CAS proteins in normal and pathological cell growth controlPathways and therapeutic targets in melanomaMetabolic rewiring in melanomaA first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumorsMalignant melanoma and melanocortin 1 receptor.Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphomaSouthwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and ResistanceMelanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigmentDNAJB6 chaperones PP2A mediated dephosphorylation of GSK3β to downregulate β-catenin transcription target, osteopontinMet amplification and tumor progression in Cdkn2a-deficient melanocytes.FISH as an effective diagnostic tool for the management of challenging melanocytic lesions.Copy number variation in archival melanoma biopsies versus benign melanocytic lesions.Genetics of melanoma progression: the rise and fall of cell senescence.Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032.NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway.Topoisomerase I amplification in melanoma is associated with more advanced tumours and poor prognosis.
P2860
Q24630247-F5A8DE83-5535-4931-8740-D38601447C40Q26865736-76A142C4-4FD4-4D61-A6BD-C540A2BA319EQ28069081-5AB5FA7F-DD25-468A-ABCB-6CC13991C28AQ33424270-3DD3A0A8-9A1A-45C0-BB6D-8CBBF17B8643Q33782773-737471D2-4C70-49F9-BEDE-7624024EA8E2Q33840504-CDD14671-D292-4E64-B450-854DB75D837AQ34679387-0B9BF35A-FBB0-4FFE-8845-6DB79F2E4F29Q35607456-29A50733-AA53-4C59-8348-FEF51350BAF1Q36752805-683CB7A1-EAB7-4DBB-84C5-BFD32B9D1E38Q37029660-FB898B26-CDAF-42D0-B4DD-40564FA99CD0Q37416083-E16B3925-AFB4-4A2A-9B53-4F844AD73ADDQ37915648-7BBECE2A-C134-4427-A819-77710086CF38Q38381518-05DB0BB7-71AB-4EE5-A2A0-E2ABC14D5BE7Q38589518-629BE6E8-8915-4BB6-9588-061A928332F4Q39412894-43A021E9-0862-4440-B98E-706D750A3EF6Q39464868-0033922C-A653-4FCD-8B2F-FB8C313946BEQ39704361-24457363-ED4D-456A-A3C1-4449719BB5F2
P2860
Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Detection of copy number alter ...... oncology group study (S9431).
@en
type
label
Detection of copy number alter ...... oncology group study (S9431).
@en
prefLabel
Detection of copy number alter ...... oncology group study (S9431).
@en
P2093
P1476
Detection of copy number alter ...... oncology group study (S9431).
@en
P2093
Diane L Persons
Dolores Bobadilla
Jeffrey A Sosman
Marilyn L Slovak
Ralph J Tuthill
Sandra R Wolman
Stephen R Moore
Vernon K Sondak
Victoria Bedell
P304
P356
10.1158/1078-0432.CCR-07-4068
P407
P577
2008-05-01T00:00:00Z